Table 1.
No. of patient (%) | |
---|---|
Characteristic | (n=56) |
Age, median (range) | 65 years (21-91 years) |
Sex | |
Male | 49 (88) |
Female | 7 (12) |
Race/ethnicity | |
Caucasian | 36 (64) |
Latino | 10 (18) |
African American | 7 (13) |
Asian | 3 (5) |
ECOG performance status | |
0-1 | 45 (80) |
2-3 | 9 (16) |
Unknown | 2 (4) |
Tumor differentiation | |
Well | 8 (14) |
Moderately | 18 (32) |
Poorly | 6 (11) |
Unknown | 24 (43) |
Hepatitis infection | |
HBV | 6 (11) |
HCV | 20 (36) |
HBV and HCV | 1 (1) |
None | 29 (52) |
Cirrhosis | |
Yes | 33 (59) |
No | 23 (41) |
Varices | |
Yes | 15 (27) |
No | 41 (73) |
Endovascular invasion | |
Yes | 30 (54) |
No | 26 (46) |
Child-Pugh score | |
A | 37 (66) |
B | 17 (30) |
C | 1 (2) |
Unknown | 1 (2) |
TNM stage | |
I | 6 (11) |
II | 8 (14) |
III | 18 (32) |
IV | 24 (43) |
CLIP score | |
0 | 8 (14) |
1 | 8 (14) |
2 | 12 (21) |
3 | 14 (25) |
4 | 4 (8) |
5 | 3 (5) |
Unknown | 7 (13) |
BCLC stage | |
0 | 1 (2) |
A | 4 (7) |
B | 6 (11) |
C | 42 (75) |
D | 3 (5) |
BCLC, Barcelona-Clinic Liver Cancer; CLIP, Cancer of the Liver Italian Program; ECOG, Eastern Cooperative Oncology Group; HBV, hepatitis B virus; HCV, hepatitis C virus.